Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase

Clinical trial NCT00369187 · COMPLETED

Trial details

NCT number: NCT00369187
Sponsor: Halozyme Therapeutics
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.